These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7865625)

  • 1. Specific interference with the determination of the tumour-associated glycoprotein 72 by human anti-idiotypic antibodies formed after treatment with the anti-tumour-associated glycoprotein 72 antibody B72.3.
    Reinsberg J; Gast B; Schmolling J; Wagner U; Krebs D
    Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):691-6. PubMed ID: 7865625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and sensitive assay for determination of human anti-idiotypic anti-B72.3 antibodies, which is not affected by the presence of tumour-associated glycoprotein 72.
    Reinsberg J; Schmolling J; Ackermann D
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):237-44. PubMed ID: 8721411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody.
    Reinsberg J; Nocke W
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):323-7. PubMed ID: 8357942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TAG-72 antibody B72.3--immunological and clinical effects in ovarian carcinoma.
    Schmolling J; Reinsberg J; Wagner U; Krebs D
    Hybridoma; 1997 Feb; 16(1):53-8. PubMed ID: 9085129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72.
    Blanco I; Kawatsu R; Harrison K; Leichner P; Augustine S; Baranowska-Kortylewicz J; Tempero M; Colcher D
    J Clin Immunol; 1997 Jan; 17(1):96-106. PubMed ID: 9049790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3.
    Ferroni P; Milenic DE; Schlom J; Colcher D
    J Clin Lab Anal; 1990; 4(6):465-73. PubMed ID: 2283566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
    Gallinger S; Reilly RM; Kirsh JC; Odze RD; Schmocker BJ; Hay K; Polihronis J; Damani MT; Shpitz B; Stern HS
    Cancer Res; 1993 Jan; 53(2):271-8. PubMed ID: 8417820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiidiotypic antibodies in ovarian cancer patients treated with the monoclonal antibody B72.3.
    Schmolling J; Reinsberg J; Wagner U; Krebs D
    Hybridoma; 1995 Apr; 14(2):183-6. PubMed ID: 7590777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
    Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
    Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies.
    Ferroni P; Milenic DE; Roselli M; Carrasquillo JA; Raubitschek A; Schlom J; Colcher D
    Int J Rad Appl Instrum B; 1991; 18(4):383-7. PubMed ID: 1864726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody.
    Khazaeli MB; Saleh MN; Liu T; Kaladas PM; Gilman SC; LoBuglio AF
    J Clin Immunol; 1992 Mar; 12(2):116-21. PubMed ID: 1373150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
    Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
    Leuk Lymphoma; 1994 May; 13(5-6):429-40. PubMed ID: 8069188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibody.
    Reinsberg J; Schultes B; Wagner U; Krebs D
    Clin Chem; 1993 May; 39(5):891-6. PubMed ID: 8485883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference by human anti-mouse antibodies in CA 125 assay after immunoscintigraphy: anti-idiotypic antibodies not neutralized by mouse IgG but removed by chromatography.
    Turpeinen U; Lehtovirta P; Alfthan H; Stenman UH
    Clin Chem; 1990 Jul; 36(7):1333-8. PubMed ID: 2372947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.
    Reinsberg J; Wagner U; Krebs D
    Arch Gynecol Obstet; 1994; 255(1):9-18. PubMed ID: 8042882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.
    Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA
    Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
    Wagner U; Reinsberg J; Krebs D
    Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours.
    Durrant LG; Doran M; Austin EB; Robins RA
    Int J Cancer; 1995 Mar; 61(1):62-6. PubMed ID: 7705934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.